Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout
Jiangxi Provincial People's Hopital
Jiangxi Provincial People's Hopital
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Sumitomo Pharma America, Inc.
University of Liverpool
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Universitätsklinikum Hamburg-Eppendorf
University of Colorado, Denver
Children's Oncology Group
Gilead Sciences
Ipsen
University of Nebraska
Duke University
US Oncology Research
Trans Tasman Radiation Oncology Group
M.D. Anderson Cancer Center
University of Catania
University of California, Davis
Mesoblast, Ltd.
Incyte Corporation
Sun Pharmaceutical Industries Limited
National Heart, Lung, and Blood Institute (NHLBI)
M.D. Anderson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
H. Lee Moffitt Cancer Center and Research Institute
UNICANCER
M.D. Anderson Cancer Center
Peking University People's Hospital
Norwegian University of Science and Technology
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
GU Research Network, LLC
OHSU Knight Cancer Institute
Children's Oncology Group
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Stanford University
University of Arizona
Dana-Farber Cancer Institute
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
M.D. Anderson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
Case Comprehensive Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Asan Medical Center